Certified by Founder Lodge
PreciseDx
United States - New York, NY
START UP
1 Disclosed Funding Rounds $20,700,000
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
PreciseDx® is innovating oncology diagnostics, leveraging Artificial Intelligence (AI) for revolutionary, morphology-driven, disease analysis. Combining AI with our patented Morphology Featur
Date | Round | Raised | Participating Investors |
---|---|---|---|
August, 22 ,2024 | Series B | $20,700,000 |